Arthritis, Rheumatoid: all 2,962 studies

Page 9 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers SquibbCompletedNCT01439204Phase 1Results posted
• TIV and High Dose TIV in Subjects With Rheumatoid ArthritisCompletedNCT01436370Phase 2Results posted
• Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA)CompletedNCT01432366Results posted
• A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) PatientsCompletedNCT01426789Phase 2Results posted
• Treatment of Vitamin D Deficiency in Patients With Rheumatoid ArthritisCompletedNCT01426347Not applicableResults posted
• Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing SpondylitisCompletedNCT01417455Results posted
• A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient DepartmentTerminatedNCT01411215Results posted
• Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid ArthritisCompletedNCT01404429Phase 4Results posted
• Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA TrialCompletedNCT01400516Phase 4Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompletedNCT01399697Phase 4Results posted
• A Relative Bioavailability and Food Effect Study of New FormulationsCompletedNCT01398475Phase 1Results posted
• An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)CompletedNCT01394276Results posted
• Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid ArthritisCompletedNCT01393639Phase 2Results posted
• A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002)TerminatedNCT01390441Phase 1Results posted
• A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in MalaysiaCompletedNCT01387789Results posted
• Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP)CompletedNCT01383421Results posted
• A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid ArthritisCompletedNCT01382940Phase 4Results posted
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα AgentsCompletedNCT01377012Phase 3Results posted
• Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)CompletedNCT01374971Phase 3Results posted
• Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to MethotrexateCompletedNCT01373151Phase 2Results posted
• A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid ArthritisCompletedNCT01369745Phase 2Results posted
• Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) TherapyCompletedNCT01362062Results posted
• Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking MethotrexateCompletedNCT01359943Phase 2Results posted
• A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or PlaceboCompletedNCT01359150Phase 2Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDsCompletedNCT01353859Phase 3Results posted
• Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee PainCompletedNCT01351805Not applicableResults posted
• Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) PatientsCompletedNCT01351480Phase 3Results posted
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)CompletedNCT01350804Phase 3Results posted
• Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069CompletedNCT01346501Results posted
• Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)CompletedNCT01346488Results posted
• A Study of RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid ArthritisCompletedNCT01332994Phase 3Results posted
• A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk FactorsCompletedNCT01331837Phase 4Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNFCompletedNCT01326962Phase 3Results posted
• A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid ArthritisCompletedNCT01317797Phase 1Results posted
• A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)CompletedNCT01313858Results posted
• A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)CompletedNCT01313520Phase 2Results posted
• Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)CompletedNCT01313208Phase 4Results posted
• An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)CompletedNCT01309282Results posted
• Effects of a Rehabilitation Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis.CompletedNCT01307787Not applicableResults posted
• Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot FusionsCompletedNCT01305356Not applicableResults posted
• Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid ArthritisCompletedNCT01299961Phase 3Results posted
• Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056TerminatedNCT01296711Phase 2Results posted
• Effects of Denosumab on the Pharmacokinetics of EtanerceptTerminatedNCT01294397Phase 1Results posted
• A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)TerminatedNCT01292265Phase 3Results posted
• Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) PatientsCompletedNCT01288287Results posted
• Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid ArthritisTerminatedNCT01285310Phase 2Results posted
• A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-InhibitorTerminatedNCT01283971Phase 4Results posted
• Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With AdalimumabCompletedNCT01282372Results posted
• GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard TherapyCompletedNCT01274182Phase 1/2Results posted
• Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With AdalimumabCompletedNCT01273519Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)CompletedNCT01272908Phase 3Results posted
• Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)TerminatedNCT01264770Phase 2Results posted
• Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid ArthritisCompletedNCT01262118Phase 1Results posted
• A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis SubjectsCompletedNCT01255761Phase 4Results posted
• An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local EnvironmentCompletedNCT01254331Phase 3Results posted
• A Study of Japanese Rheumatoid Arthritis ParticipantsCompletedNCT01253291Phase 1Results posted
• A Study in Rheumatoid ArthritisCompletedNCT01253265Phase 1Results posted
• A Study for Japanese Participants With Rheumatoid Arthritis (RA)CompletedNCT01253226Phase 1Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid ArthritisTerminatedNCT01251120Phase 4Results posted
• Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT01248780Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01245439Phase 3Results posted
• Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)TerminatedNCT01242514Phase 3Results posted
• A Study of LY2439821 in Rheumatoid ArthritisCompletedNCT01236118Phase 1Results posted
• Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT01235598Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)CompletedNCT01235507Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT01232569Phase 3Results posted
• A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid ArthritisCompletedNCT01231321Phase 3Results posted
• Milnacipran for Treatment of Pain in Older Adults With Rheumatoid ArthritisCompletedNCT01225991Phase 4Results posted
• A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)CompletedNCT01219933Phase 4Results posted
• Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α BlockersTerminatedNCT01217814Phase 2Results posted
• An Open Label Study for Participants With Rheumatoid ArthritisTerminatedNCT01215942Phase 3Results posted
• A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)CompletedNCT01208181Phase 3Results posted
• Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid ArthritisCompletedNCT01207453Phase 4Results posted
• A Study in Participants With Rheumatoid ArthritisTerminatedNCT01202773Phase 3Results posted
• A Rheumatoid Arthritis Study in ParticipantsCompletedNCT01202760Phase 3Results posted
• Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)CompletedNCT01198509Not applicableResults posted
• A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateTerminatedNCT01198002Phase 3Results posted
• Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha AntagonistCompletedNCT01197755Phase 3Results posted
• Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.CompletedNCT01197534Phase 3Results posted
• Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.CompletedNCT01197521Phase 3Results posted
• A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.CompletedNCT01195272Phase 4Results posted
• A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT01194414Phase 3Results posted
• An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS)CompletedNCT01185522Results posted
• A Study in Participants With Rheumatoid Arthritis on Background Methotrexate TherapyCompletedNCT01185353Phase 2Results posted
• Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)CompletedNCT01185301Phase 3Results posted
• A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)CompletedNCT01185288Phase 4Results posted
• Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)CompletedNCT01181050Phase 2Results posted
• Methotrexate - Inadequate Response Device Sub-StudyCompletedNCT01173120Phase 3Results posted
• Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.CompletedNCT01172639Phase 4Results posted
• Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)CompletedNCT01164579Phase 2Results posted
• Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical CareCompletedNCT01163916Results posted
• A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)CompletedNCT01163747Phase 4Results posted
• The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis PatientsCompletedNCT01163617Phase 2Results posted
• Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid ArthritisCompletedNCT01163318Results posted
• Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))CompletedNCT01163292Results posted
• A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid ArthritisCompletedNCT01162421Phase 4Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDSCompletedNCT01149057Phase 4Results posted
• Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to CimziaCompletedNCT01147341Phase 4Results posted
• Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)CompletedNCT01146652Phase 3Results posted
• Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in TurkeyCompletedNCT01144598Results posted

← Arthritis, Rheumatoid overview